Skip to content

Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study

Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00715312
Enrollment
43
Registered
2008-07-15
Start date
2008-02-29
Completion date
2008-06-30
Last updated
2008-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation

Keywords

Inflammation, LDL, Oleic acid, Palmitic acid, trans fatty acid, C-reactive protein

Brief summary

Rationale: The effect of positional distribution of dietary fatty acids on markers of inflammation and blood lipids metabolites on diets containing fatty acids such as oleic acid that are associated with reduced risk of cardiovascular disease is not widely studied. Hypothesis: There would be difference detected in the concentrations of markers of inflammation and blood lipid metabolites in human volunteers fed controlled diets. Study design: A randomized, double-blind, crossover clinical trial that involves 41 healthy volunteers. The volunteers will be selected based on inclusion and exclusion criteria. They will consume controlled diets for 5 weeks that provides 15% of energy from protein, 30% of energy from fat, and 55% of energy from carbohydrates. Volunteers will be assigned to each test diets which is cooked with novel olein, palm stearin or partially hydrogenated soybean oil in random order until all three diets has consumed by each person. Main study parameters: LDL-cholesterol

Interventions

OTHERNovel Olein

A total of 70g of test oil is incorporated into cooked meal which accounts for 30-35% of calorie intake

Sponsors

Malaysia Palm Oil Board
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy and free from any disease and absence of family history for arteriosclerosis or hypertension * Not on any medication or supplements or weight loss program * Non smokers and alcoholics

Exclusion criteria

* Having some health-related problems e.g fever, flu, allergy, chronic diseases * On some treatment or medication * Smokers and alcoholics

Design outcomes

Primary

MeasureTime frame
LDL-cholesterol5 weeks

Secondary

MeasureTime frame
C-reactive protein5 weeks

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026